Latest News
HSBC lifts Intertek target price, highlights risks from trade protectionism
HSBC raised its target price on shares of Intertek sharply higher even as it enumerated a long list of potential headwinds which the company might face.
BOS Global patents looking likely in Australia
Employee productivity software developer BOS Global Holdings confirmed on Friday that IP Australia issued reports on its Australian patent applications 2017200601 for ‘Managing Activities Performed By Users’ and 2017200602 for ‘Verifying Time Based Services’, where all claims were considered to be novel, inventive and to constitute patentable subject matter.
Credit Suisse spies higher dividend payouts at G4S
Credit Suisse bumped up its target price on shares of G4S as it spied a return to increased dividend payouts as the company continued to put its house in order while slashing away at its gearing.
Canaccord says positive tailwinds already largely factored into Wolseley
Analysts at Canaccord Genuity revised their target on Wolseley sharply higher ahead of the company's interim results due to be published on 28 March.
Pennant International reverses to FY profit and suspends final dividend
Shares in Pennant International are up more than 5% after it reversed from loss to full-year profit, roughly doubled its revenue and suspended its final dividend.
UK industrial output stumble signals GDP slowdown
UK industrial output shrank in January as manufacturing activity slowed, official figures showed on Friday, which added to the expectation that the economy is heading for contraction in the first quarter.
US non-farm payrolls rise by 235,000 in February, beat forecasts
Job creation in the US kept up at a solid pace in February amid solid growth in workers' earnings, eliminating the last potential hurdle for an interest rate hike at the central bank's policy meeting the following week.
Clinigen anti-epileptic drug approved in South Africa
AIM-listed pharmaceutical Clinigen’s adult anti-epileptic drug has been approved in South Africa.
Brexit could cost Spain €1bn in exports, leaked report says
A leaked report from the Spanish government has detailed how the country could lose up to €1bn in exports as a result of Britain's departure from the European Union, according to a leaked report from the central government in Madrid.
Results round-up: Esure Group, JRP Group, Wetherspoon
Motor and home insurer Esure Group said it was now in "full growth mode" as underlying profit surged 20% in 2016, with premiums ahead of expectations and barely any effect from the now infamous changes to the 'Ogden' rate.
Europe midday: Stocks higher after positive ECB message, euro rallies
European stocks were in the green on Friday, gaining from the European Central Bank's positive message the previous session, while the euro rallied and oil prices recovered from record lows.
US pre-open: Stocks to open slightly higher as investors eye non-farm payroll
Ahead of the releases of the all-important non-farm payroll report, US futures pointed to a higher open on Wall Street as oil prices rebounded.
Kodal surges on news of investment, potential off-take agreement, placing with Suay Chin
Shares in Kodal Minerals surged on news of a £4. 3m strategic investment, potential off-take agreement and £500,000 placing, all with Suay Chin International.
EPA boss denies effect of carbon dioxide on the environment
The head of the US Environmental Protection Agency has denied that carbon dioxide emissions have a significant impact on global warming.
Midatech Pharma updates on Bilbao manufacturing site
Midatech Pharma's shares are up almost 2% after confirming the successful initial scale-up and regulatory inspection of its state-of-the-art manufacturing site in Bilbao, Spain.
Asiamet upbeat on ongoing infill drilling at Beruang Kanan
Asiamet Resources advised on Friday that resource infill and extension drilling being completed as part of feasibility studies on the Beruang Kanan Main copper deposit in Central Kalimantan, Indonesia was continuing to substantially de-risk the resource.
Oxford Pharmascience narrows loss as it develops OXPzero
Speciality pharmaceutical company Oxford Pharmascience Group announced its results for the year ended 31 December on Friday - a year in which it completed its technical programme to improve release properties, and successfully completed in vivo demonstrations that its technology modifications could make its OXPzero ibuprofen bioequivalent to the reference product and also potentially faster acting.
PBoC governor reiterates pledge to maintain yuan's value stable
The head of China's central bank reiterated a pledge to keep the value of the value of the yuan stable, while stressing the need for tighter monetary policy to prod firms into reducing excess capacity and leverage.
Green REIT exchanges contracts on Parkway Retail Park
Green REIT announced on Friday that it exchanged contracts for the sale of Parkway Retail Park in Limerick, with completion expected by the end of March.
Highlands Natural Resources enhances land position in Nobrara shale play
Shares in Highlands Natural Resources are down almost 4% after it executed an expanded agreement with Renegade Oil & Gas Company LLC, significantly enhancing its land position in its East Denver, Colorado, Niobrara shale play.